Evidence map›Paper›PMID 37625852›Full record

ArticleRNA (New York, N.Y.)2023

Biochemical and genetic evidence supports Fyv6 as a second-step splicing factor in

Karli A Lipinski, Katherine A Senn, Natalie J Zeps, Aaron A Hoskins

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Control of 3' splice site selection inRNA (New York, N.Y.) · 2025
    Article
  2. Article
  3. Article
  4. Control of 3' splice site selection by the yeast splicing factor Fyv6.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Karli A Lipinski *Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.ORCID 0000-0002-4271-1586
Katherine A Senn *Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.ORCID 0000-0003-2172-7113
Natalie J ZepsDepartment of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Aaron A HoskinsDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA ahoskins@wisc.edu.ORCID 0000-0002-9777-519X
University of Wisconsin–Madison · US

Funding

Biotechnology Training ProgramT32GM135066 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI SCOTT M. COYLE, BRIAN G FOX · 2020 to 2026
$7.0M
Mechanisms of Spliceosome Assembly and RegulationR35GM136261 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Aaron Andrew Hoskins · 2020 to 2026
$3.2M
NIGMS NIH HHS R35 GM136261NIGMS NIH HHS T32 GM135066
6 · The paper itself

Abstract

Precursor mRNA (pre-mRNA) splicing is an essential process for gene expression in eukaryotes catalyzed by the spliceosome in two transesterification steps. The spliceosome is a large, highly dynamic complex composed of five small nuclear RNAs and dozens of proteins, some of which are needed throughout the splicing reaction while others only act during specific stages. The human protein FAM192A was recently proposed to be a splicing factor that functions during the second transesterification step, exon ligation, based on analysis of cryo-electron microscopy (cryo-EM) density. It was also proposed that Fyv6 might be the

Indexed as

RNA Splicing FactorsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCryoelectron MicroscopyRNA PrecursorsRNA SplicingSpliceosomesFyv6 protein, Saccharomyces cerevisiaeRNA PrecursorsRNA Splicing FactorsSaccharomyces cerevisiae ProteinsFAM192AFyv6RNA splicingspliceosomeyeast

Identifiers

PMID37625852
PMCPMC10578475
OpenAlexW4386155498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.